Literature DB >> 2387631

Cryptosporidium parvum (Apicomplexa: Cryptosporidiidae) oocyst and sporozoite antigens recognized by bovine colostral antibodies.

M Tilley1, R Fayer, A Guidry, S J Upton, B L Blagburn.   

Abstract

Colostral whey from seven hyperimmunized and two control cows (hyperimmune bovine colostrum) was examined by Western immunoblotting for the presence of antibody against oocysts and sporozoites of Cryptosporidium parvum, using rabbit anti-bovine immunoglobulin A (IgA), IgG1, IgG2, and IgM antibodies, followed by a horseradish peroxidase goat anti-rabbit polyvalent antibody. Although considerable variation was found in binding activity between cows on different immunization protocols, IgA and IgG1 in whey recognized a greater variety of C. parvum antigens than did IgG2 and IgM. A band at 9 to 10 kilodaltons appeared unique in that it was recognized only by IgA.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2387631      PMCID： PMC313596          DOI： 10.1128/iai.58.9.2966-2971.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  31 in total

1.  Localization of a 23,000 MW antigen of Cryptosporidium by immunoelectron microscopy.

Authors:  R Lumb; P S Smith; R Davies; P J O'Donoghue; H M Atkinson; J A Lanser
Journal:  Immunol Cell Biol       Date:  1989-08       Impact factor: 5.126

2.  Hyperimmune bovine colostrum neutralizes Cryptosporidium sporozoites and protects mice against oocyst challenge.

Authors:  R Fayer; L E Perryman; M W Riggs
Journal:  J Parasitol       Date:  1989-02       Impact factor: 1.276

3.  Infection and diarrhea caused by Cryptosporidium sp. among Guatemalan infants.

Authors:  J R Cruz; F Cano; P Càceres; F Chew; G Pareja
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

4.  Lacteal immunity to enteric cryptosporidiosis in mice: immune dams do not protect their suckling pups.

Authors:  H W Moon; D B Woodmansee; J A Harp; S Abel; B L Ungar
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

5.  Neutralization-sensitive epitopes are exposed on the surface of infectious Cryptosporidium parvum sporozoites.

Authors:  M W Riggs; T C McGuire; P H Mason; L E Perryman
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

6.  Identification of outer oocyst wall proteins of three Cryptosporidium (Apicomplexa: Cryptosporidiidae) species by 125I surface labeling.

Authors:  M Tilley; S J Upton; B L Blagburn; B C Anderson
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

7.  Efficacy of hyperimmune bovine colostrum for prophylaxis of cryptosporidiosis in neonatal calves.

Authors:  R Fayer; C Andrews; B L Ungar; B Blagburn
Journal:  J Parasitol       Date:  1989-06       Impact factor: 1.276

8.  Rotavirus and Cryptosporidium shedding in dairy calf feces and its relationship to colostrum immune transfer.

Authors:  J W Lopez; S D Allen; J Mitchell; M Quinn
Journal:  J Dairy Sci       Date:  1988-05       Impact factor: 4.034

9.  Electrophoretic and immunoblot analysis of Cryptosporidium oocysts.

Authors:  R Lumb; J A Lanser; P J O'Donoghue
Journal:  Immunol Cell Biol       Date:  1988 Oct-Dec       Impact factor: 5.126

10.  Effects of immune colostrum and orally administered antisporozoite monoclonal antibodies on the outcome of Cryptosporidium parvum infections in neonatal mice.

Authors:  M J Arrowood; J R Mead; J L Mahrt; C R Sterling
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441
View more
  15 in total

1.  Obtaining hyperimmune anti-Cryptosporidium parvum ovine colostrum. A study of the humoral immune response in immunized sheep.

Authors:  S Martín-Gómez; M A Alvarez-Sánchez; F A Rojo-Vázquez
Journal:  Parasitol Res       Date:  2005-11-16       Impact factor: 2.289

2.  Cryptosporidium parvum in calves: kinetics and immunoblot analysis of specific serum and local antibody responses (immunoglobulin A [IgA], IgG, and IgM) after natural and experimental infections.

Authors:  J E Peeters; I Villacorta; E Vanopdenbosch; D Vandergheynst; M Naciri; E Ares-Mazás; P Yvoré
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

3.  Identification and initial characterization of five Cryptosporidium parvum sporozoite antigen genes.

Authors:  C Petersen; J Gut; J H Leech; R G Nelson
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

4.  Cloning and expression of a DNA sequence encoding a 41-kilodalton Cryptosporidium parvum oocyst wall protein.

Authors:  M C Jenkins; J Trout; C Murphy; J A Harp; J Higgins; W Wergin; R Fayer
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

5.  Recombinant proteins of Cryptosporidium parvum induce proliferation of mesenteric lymph node cells in infected mice.

Authors:  Inderpal Singh; Cynthia Theodos; Saul Tzipori
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

6.  Evidence that surface proteins Sn14 and Sn16 of Sarcocystis neurona merozoites are involved in infection and immunity.

Authors:  F T Liang; D E Granstrom; X M Zhao; J F Timoney
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

7.  Cross-reactivity of polyclonal serum antibodies generated against Cryptosporidium parvum oocysts.

Authors:  L M Ortega-Mora; J M Troncoso; F A Rojo-Vázquez; M Gómez-Bautista
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

8.  Anti-Cryptosporidium parvum antibodies inhibit infectivity in vitro and in vivo.

Authors:  P S Doyle; J Crabb; C Petersen
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

9.  Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite precipitate-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice.

Authors:  M W Riggs; V A Cama; H L Leary; C R Sterling
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

Review 10.  Cryptosporidiosis.

Authors:  W L Current; L S Garcia
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.